Tokyo Tape
Sign in
← Fuso Pharmaceutical Industries

Quarterly report · Q3

4538.TEDINET S100SURX
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 37
MetricValuePeriodScopeSource row
Revenue¥42.8bn2023-04-01 → 2023-12-31StandaloneNet sales
Revenue¥51.0bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥39.2bn2022-04-01 → 2022-12-31StandaloneNet sales
Operating income¥1.8bn2023-04-01 → 2023-12-31StandaloneOperating income
Operating income¥2.0bn2022-04-01 → 2022-12-31StandaloneOperating income
Ordinary income¥1.8bn2023-04-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥2.2bn2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥2.1bn2022-04-01 → 2022-12-31StandaloneOrdinary income
Profit before tax¥1.7bn2023-04-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥2.1bn2022-04-01 → 2022-12-31StandaloneIncome before income taxes
Net income¥1.2bn2023-04-01 → 2023-12-31StandaloneProfit loss
Net income¥1.6bn2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income¥1.5bn2022-04-01 → 2022-12-31StandaloneProfit loss
Total assets¥77.7bnat 2023-12-31StandaloneAssets
Total assets¥72.5bnat 2023-03-31StandaloneAssets
Total assets¥73.0bnat 2022-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥41.6bnat 2023-12-31StandaloneLiabilities
Total liabilities¥36.8bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥36.1bnat 2023-12-31StandaloneNet assets
Net assets / equity¥35.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥35.6bnat 2022-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥6.7bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥8.0bnat 2023-03-31StandaloneCash and deposits
EPS (basic)¥141.922023-04-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥60.282023-10-01 → 2023-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥183.072022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥170.32022-04-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥54.172022-10-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥352023-04-01 → 2023-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥702022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥302022-04-01 → 2022-12-31StandaloneDividend paid per share (5-year summary)
Equity ratio46.4%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio49.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio48.7%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued9,451,169at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2022-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 278
ItemContextValueUnit
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember8865000000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember1965000000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember1843000000JPY
Interest and dividends income noiPrior1YTDDuration_NonConsolidatedMember88000000JPY
Interest and dividends income noiCurrentYTDDuration_NonConsolidatedMember95000000JPY
Gain on sales of investment securities noiPrior1YTDDuration_NonConsolidatedMember138000000JPY
Gain on sales of investment securities noiCurrentYTDDuration_NonConsolidatedMember－JPY
Insurance income noiPrior1YTDDuration_NonConsolidatedMember82000000JPY
Insurance income noiCurrentYTDDuration_NonConsolidatedMember77000000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember40000000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember52000000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember350000000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember225000000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember125000000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember127000000JPY
Life insurance experses noePrior1YTDDuration_NonConsolidatedMember74000000JPY
Life insurance experses noeCurrentYTDDuration_NonConsolidatedMember75000000JPY
Other noePrior1YTDDuration_NonConsolidatedMember55000000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember36000000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember255000000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember239000000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember2060000000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember1829000000JPY
Gain on sales of investment securities eiPrior1YTDDuration_NonConsolidatedMember－JPY
Gain on sales of investment securities eiCurrentYTDDuration_NonConsolidatedMember39000000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember－JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember39000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration_NonConsolidatedMember7000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration_NonConsolidatedMember20000000JPY
Loss on valuation of investment securities elPrior1YTDDuration_NonConsolidatedMember－JPY
Loss on valuation of investment securities elCurrentYTDDuration_NonConsolidatedMember110000000JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember7000000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember130000000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember2053000000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember1738000000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember329000000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember357000000JPY
Income taxes deferredPrior1YTDDuration_NonConsolidatedMember230000000JPY
Income taxes deferredCurrentYTDDuration_NonConsolidatedMember153000000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember559000000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember510000000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember1493000000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember1227000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-02-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第101期第３四半期(自 2023年10月１日　至 2023年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)扶桑薬品工業株式会社
Company name in english cover pageFilingDateInstantFuso Pharmaceutical Industries, Ltd.

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass